Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.307
Buy
RSI(14)
55.850
Neutral
STOCH(KDJ)(9,3,3)
69.601
Neutral
ATR(14)
0.870
Low Volatility
CCI(14)
86.168
Neutral
Williams %R
38.484
Buy
TRIX(12,20)
0.312
Sell
StochRSI(14)
0.000
Sell
Search
Brainsway Ltd
BWAYAdd to Watchlist
15.662USD
-0.308-1.93%
Market hours （ET）Quotes delayed by 15 min
613.43MMarket Cap
34.15P/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-2.07%
5 Days
-0.58%
1 Month
+8.00%
6 Months
-36.71%
Year to Date
-17.78%
1 Year
+33.32%
Key Figures
16.100Open
16.510High
79.56KVolume
34.15P/E TTM
31.08P/E Dynamic
--Dividend TTM
0.20%Turnover Ratio
15.970Prev. Close
15.550Low
1.10MTurnover
210.01P/E Static
7.85P/B
0.00%Div Yield TTM
8.06%ROA
17.35252wk High
1.57Volume Ratio
2.92MNet Profit
39.17MShares
0.4586EPS TTM
1.21Beta
11.75%ROE
5.00552wk Low
6.01%Amplitude
75.17%Gross Margin
613.43MMarket Cap
3.97Reward/Risk
2.59%Risk Rate
TradingKey Stock Score of Brainsway Ltd
Currency: USD Updated: 2026-07-24Key Insights
Brainsway Ltd's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 79 out of 200 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 17.67.In the medium term, the stock price is expected to remain stable.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Brainsway Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Brainsway Ltd Highlights
StrengthsRisks
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 64.31% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 52.23M.
Fairly Valued
The company’s latest PE is 34.82, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 12.27M shares, decreasing 20.62% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 82.90K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.20.
Analyst Rating
Based on
3
analysts
Strong Buy
Current Rating
17.667
Target Price
+7.01%
Upside Space
Brainsway Ltd News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
3
analysts
Strong Buy
Current Rating
17.667
Target Price
+7.01%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Brainsway Ltd
BWAY
3
Intuitive Surgical Inc
ISRG
35
Boston Scientific Corp
BSX
34
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
18
Indicators
Moving Average
Indicators
Value
Direction
MA5
16.338
Sell
MA10
15.570
Buy
MA20
15.372
Buy
MA50
15.071
Buy
MA100
14.782
Buy
MA200
17.027
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Brainsway Ltd Info
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Ticker SymbolBWAY
CompanyBrainsway Ltd
CEOLevy (Hadar)
Websitehttps://www.brainsway.com/
Shareholders
Related Instruments
-0.70%
-0.35%
+2.02%
+0.92%
-0.96%
+1.91%
+5.22%
+2.08%
+1.46%
-0.26%
+0.22%
+3.99%
+0.56%
-1.10%
-1.99%
+3.05%
+2.10%
+0.00%
-1.21%
-0.14%Popular Instruments
52207.400
+307.400 (+0.59%)
28001.800
-148.600 (-0.53%)
7419.300
+11.200 (+0.15%)
15105.000
+157.000 (+1.05%)
63933.000
-286.000 (-0.45%)
6311.700
+47.200 (+0.75%)
82.777
-7.266 (-8.07%)
337.055
+4.035 (+1.21%)
198.750
-8.090 (-3.91%)
4072.770
+20.420 (+0.50%)
FAQs
What is the current price of Brainsway Ltd (BWAY)?
The current price of Brainsway Ltd (BWAY) is 15.97.
What is the symbol of Brainsway Ltd?
The ticker symbol of Brainsway Ltd is BWAY.
What is the 52-week high of Brainsway Ltd?
The 52-week high of Brainsway Ltd is 17.35.
What is the 52-week low of Brainsway Ltd?
The 52-week low of Brainsway Ltd is 5.00.
What is the market capitalization of Brainsway Ltd?
The market capitalization of Brainsway Ltd is 661.55M.
Is Brainsway Ltd (BWAY) currently rated as Buy, Hold, or Sell?
According to analysts, Brainsway Ltd (BWAY) has an overall rating of STRONG BUY, with a price target of 17.67.
What is the Earnings Per Share (EPS TTM) of Brainsway Ltd (BWAY)?
The Earnings Per Share (EPS TTM) of Brainsway Ltd (BWAY) is 0.40.